Top 5 Beyond Celiac research news articles of 2021
After years of working to accelerate celiac disease science, Beyond Celiac was thrilled to see a burst of new and exciting research published in 2021
Opt-in to stay up-to-date on the latest news.
After years of working to accelerate celiac disease science, Beyond Celiac was thrilled to see a burst of new and exciting research published in 2021
People with celiac disease get more headaches, including migraines, and women get more migraines than men, according to a new study.
The reliability of urine tests to determine how much gluten might be getting into the gluten-free diet is questioned in a new study. Meanwhile other scientists defend the accuracy of the tests based on the results of previous research.
Monoclonal antibodies can be used for treating many different types of disease and are being studied in celiac disease after showing proof-of-concept in earlier trials
If you are Black or have public insurance and also have symptoms associated with celiac disease or inflammatory bowel disease, your chance of getting proper follow-up for diagnosis is greatly reduced, a recent study found.
Children who had no symptoms but were diagnosed with celiac disease as part of a mass pediatric screening program reported a better quality of life overall after a year on the gluten-free diet, preliminary results of a study funded by Beyond Celiac show.
An international group of researchers are investigating a monoclonal antibody that has the potential to treat celiac disease by stopping the activation of cells that identify gluten as an invader.
Italian researchers hypothesize that COVID-19 could have implications for those who are genetically at risk for celiac disease
The mouth and the intestine share characteristics that might make a saliva test for celiac disease the first step in diagnosis, a new study from Spain suggests.
Two European studies paint a discouraging picture of how well celiac disease is understood in the medical community. Some of what they conclude is likely to be applicable to the United States, too.
Intestinal changes that occur before the development of celiac disease in at-risk children have been identified in a new study. The results are promising for potentially identifying ways to intervene before celiac disease develops, according to study authors.
PRV-015 has previously been studied for its potential to reduce symptoms and inflammation triggered by gluten in people with celiac disease.
Recently, the European Academy of Dermatology and Venereology compiled guidelines to support dermatologists in diagnosis and treatment of DH and improve the quality of management for patients.
A new drug being investigated to treat celiac disease reduced intestinal damage in patients undergoing a gluten challenge, early results reported in a new study found.
The breast milk of mothers with celiac disease on a gluten-free diet is not functionally different from the breast milk of mothers who don't have celiac disease, a new study finds.
Brain fog is a symptom that gets a lot of attention in the celiac disease and non-celiac gluten sensitivity communities, but not as much attention from researchers.
Mass screening program finds high rates of celiac disease in children.
A new study, published in the Journal of Clinical Gastroenterology, calls the sensitivity of the TTG-IgA test for celiac disease into question and raises the issue of frequent false negatives.
Early results of research into the symptoms that would prompt someone to take a drug to treat celiac disease, the relationship between celiac disease and disordered eating, and the number of workdays lost due to celiac disease were presented at a recent meeting of gastroenterologists.
A new survey reveals dating difficulty for those who have celiac disease. One in five said the overall dating experience is not enjoyable. Nearly 40 percent are uncomfortable on a date when they have to explain their need for gluten-free food to restaurant servers. Nearly 30 percent take risks when eating and eight percent have eaten gluten knowingly
Latiglutenase development continues with initial CeliacShield™ study results and ongoing Solutions for Celiac™ clinical study actively recruiting participants
A new study shows that people with celiac disease perceived they were at great risk from COVID-19. Worry about additional risk, however, dropped as the pandemic progressed and more information, primarily from celiac disease associations, became available.
A new approach to treating celiac disease by using nanoparticles to program the immune system to tolerate gluten showed promise in early results, according to a newly published study.
Recent data from the Go Beyond Celiac Gluten Exposure Survey highlights a number of neurological and psychological symptoms that celiac disease patients report experiencing after exposure to gluten, adding to the call that patients truly experience more than just GI troubles.
ACeD Study launched second part of clinical trial last month
Opt-in to stay up-to-date on the latest news.
Yes, I want to advance research No, I'd prefer not to